Despite decades of research effort directed towards understanding the basic biology, etiology, prevention, and means of treatment of malignant disease, cancer remains one of the most serious health problems for the US population. Over 1.4 million new cancer cases are diagnosed each year and over one half million persons will die as a consequence. Approximately 40% of men and 33% of women in the US will develop cancer by their 85th birthday. The need for this interdisciplinary training program in cancer epidemiology and biostatistics has never been greater. The virtual explosion in recent years of new knowledge regarding the biological mechanisms underlying the development of cancer, particularly at the molecular level and in regard to the role of genetic determinants, continues to accelerate, presenting both new challenges and unprecedented opportunities within the public health sciences field to translate this knowledge from new technologies into significant improvements in incidence and mortality from cancer. The purpose of the University of Washington's long-standing training program in cancer epidemiology and biostatistics is to provide the highest level of training and experience in these closely-related disciplines that will enable the trainee to address this problem through the conduct of high quality cancer research. The program is housed in the Departments of Epidemiology and Biostatistics in the School of Public Health of the University of Washington. All of the predoctoral trainees and most of the postdoctoral trainees have been enrolled in the graduate programs that these departments offer. Much of the training also takes place at our affiliated institution, the Fred Hutchinson Cancer Research Center. For the new award period we propose to train seven predoctoral students (enrolled in the epidemiology or biostatistics PhD program, and four postdoctoral trainees (most within a few years of their doctorate). The Training Grant has been in operation now for 35 years. Of the approximately 160 trainees that have entered through the program, most have had backgrounds in the health professions, science, and/or mathematics. Our program's record has been a good one. With very few exceptions, all positions on the training grant have been filled, and the overwhelming majority of the trainees who began the program have completed it. In addition, nearly all trainees who completed the program have pursued careers in science or public health, and they have produced a large quantity of noteworthy cancer research, both while they were in the training program and afterwards. The past award period has seen a significant increases in the number of trainees from underrepresented minority groups compared to past years. A minor change in this revised application is a new co-Director representing the Biostatistics Department.

Public Health Relevance

Cancer remains a major health problem in the US, killing over 500,000 persons per year. In recent years, rapid progress in technology has provided the means to generate new knowledge relevant to the causes of cancer, including inherited predisposition, as well as means of early detection of cancer, when it is most curable. The proposed training program will provide graduate students and recent graduates from medical and doctoral programs with a high level of training and experience to enable them to make significant contributions in their careers to the prevention and treatment of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009168-37
Application #
8548234
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
1980-07-01
Project End
2017-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
37
Fiscal Year
2013
Total Cost
$382,402
Indirect Cost
$27,456
Name
University of Washington
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Kocarnik, Jonathan M; Fullerton, Stephanie M (2014) Returning pleiotropic results from genetic testing to patients and research participants. JAMA 311:795-6
Adams, Scott V; Quraishi, Sabah M; Shafer, Martin M et al. (2014) Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women's Health Initiative. Environ Health Perspect 122:594-600
Lowry, Sarah J; Malone, Kathleen E; Cushing-Haugen, Kara L et al. (2014) The risk of breast cancer associated with specific patterns of migraine history. Cancer Causes Control 25:1707-15
Resler, Alexa J; Makar, Karen W; Heath, Laura et al. (2014) Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry. Carcinogenesis 35:2121-6
Wright, Jonathan L; Hansten, Philip D; Stanford, Janet L (2014) Is digoxin use for cardiovascular disease associated with risk of prostate cancer? Prostate 74:97-102
Beaber, Elisabeth F; Malone, Kathleen E; Tang, Mei-Tzu Chen et al. (2014) Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiol Biomarkers Prev 23:755-64
Bodelon, Clara; Madeleine, Margaret M; Johnson, Lisa G et al. (2014) Genetic variation in the TLR and NF-*B pathways and cervical and vulvar cancer risk: a population-based case-control study. Int J Cancer 134:437-44
Scherer, Dominique; Koepl, Lisel M; Poole, Elizabeth M et al. (2014) Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry. Genes Chromosomes Cancer 53:568-78
Kocarnik, Jonathan M; Pendergrass, Sarah A; Carty, Cara L et al. (2014) Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study. Circ Cardiovasc Genet 7:178-88
Zelnick, Leila R; Morrison, Laurie J; Devlin, Sean M et al. (2014) Addressing the challenges of obtaining functional outcomes in traumatic brain injury research: missing data patterns, timing of follow-up, and three prognostic models. J Neurotrauma 31:1029-38

Showing the most recent 10 out of 179 publications